Urologic Oncology

January 24, 2024

Long-term follow-up pinpoints side effects of treatments for prostate cancer patients

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

By Craig Boerner
June 8, 2023

Study finds Mark Cuban’s Cost Plus Drug Company could save taxpayers millions on Medicare generic oncology drugs

Vanderbilt research finds that the U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

By Craig Boerner
April 3, 2023

More U.S. prostate cancer patients choosing active surveillance

A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers.

By Craig Boerner
August 17, 2022

Donation leads to lectureship for Urologic Oncology

A generous donation is leading to the Hassell Franklin Lectureship for the Division of Urologic Oncology at Vanderbilt University Medical Center.

By Craig Boerner
August 6, 2020

Davis named senior medical director for VICC Cancer Care Network and Strategy

Nancy Davis, MD, has been named senior medical director for VICC Cancer Care Network and Strategy, a new leadership position at Vanderbilt-Ingram Cancer Center responsible for expanding cancer clinics within and beyond the Middle Tennessee catchment area.

By Tom Wilemon
August 26, 2019

New Physician Spotlight: Niels Johnsen

Niels Johnsen, MD, has joined the Vanderbilt University Medical Center Department of Urology after completing his residency at VUMC. He began seeing patients Aug. 1.

By VUMC News and Communications
March 28, 2019

Tool guides decision-making for prostate cancer patients

Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
By Craig Boerner
April 20, 2017

Prostate cancer screening recommendations altered for some older men

A federal task force has changed its recommendation about prostate cancer screening for some older men. The United States Preventive Services Task Force (USPSTF) now recommends that men between the ages of 55 to 69 consult with their physicians about getting routine screening blood tests to detect prostate cancer.
By VUMC News and Communications
April 16, 2015

Study shows statin use improves renal cell cancer survival

A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival.
By VUMC News and Communications
May 22, 2014

Urologic cancer studies point to need for referral education

Women with blood in their urine (hematuria) were less than half as likely as men with the same issue to be referred to a urologist for further tests, according to a new VUMC study.
By VUMC News and Communications